Benitec Biopharma Inc.
8.65USD
-0.1700 (-1.93%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BNTC.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.29▼ | -$0.28 | 1 | 2 |
| Next quarter | -$0.3▼ | -$0.3 | 1 | 1 |
| Current year | -$1.22▼ | -$1.15 | 0 | 3 |
| Next year | -$1.43▼ | -$1.21 | 0 | 2 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.27 | -$0.26 | +0.01 (+1.9%) |
| 2026-03-31 | -$0.28 | -$0.24 | +0.04 (+12.7%) |
| 2025-12-31 | -$0.23 | -$0.26 | -0.03 (-15.0%) |
| 2025-09-30 | -$0.36 | -$0.22 | +0.14 (+38.2%) |
24 ratings from 12 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Raymond James | Initiated | Outperform | $14 | Oct 23, 2026 |
| Wedbush | Maintained | Outperform | $16 $17 | Sep 15, 2026 |
| Wedbush | Initiated | Outperform | $16 | Jul 28, 2026 |
| Evercore ISI Group | Initiated | Outperform | $25 | May 12, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $32 | Mar 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $35 $32 | Nov 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $28 $35 | Nov 4, 2025 |
| Citizens | Maintained | Market Outperform | $20 $22 | Nov 4, 2025 |
| JMP Securities | Reiterated | Market Outperform | $20 | Sep 24, 2025 |
| Oppenheimer | Maintained | Outperform | $35 $29 | Sep 16, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $28 | May 19, 2025 |
| JMP Securities | Reiterated | Market Outperform | $20 | May 15, 2025 |
| JMP Securities | Maintained | Market Outperform | $18 $20 | Apr 10, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $28 | Mar 24, 2025 |
| Citizens Capital Markets | Reiterated | Market Outperform | $18 | Mar 18, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $28 | Feb 21, 2025 |
| Baird | Initiated | Outperform | $30 | Dec 13, 2024 |
| Guggenheim | Reiterated | Buy | $17 | Dec 3, 2024 |
| Leerink Partners | Initiated | Outperform | $13 | Jul 22, 2024 |
| Piper Sandler | Initiated | Overweight | $30 | Jun 13, 2024 |
| JMP Securities | Maintained | Market Outperform | $10 $16 | Apr 22, 2024 |
| JMP Securities | Maintained | Market Outperform | $8 $10 | Feb 15, 2024 |
| JMP Securities | Maintained | Market Outperform | $6 $8 | Jan 24, 2024 |
| JMP Securities | Maintained | Market Outperform | $4 $6 | Sep 26, 2023 |
12 filings from 2 insiders · 0 buy / 0 sell over 6m
Officers and directors of BNTC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BUCHI J. KEVINDirector | Gift | 51.8k | — | — | Jun 29, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 144.2k | $12.85 | $1.90M | Dec 29, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 46.1k | $11.24 | $539k | Dec 22, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 1.48M | $13.50 | $20.00M | Nov 7, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 16.5k | $12.63 | $212k | Mar 31, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 900.0k | $13.00 | $11.70M | Mar 26, 2025 |
| BUCHI J. KEVINDirector | Gift | 103.6k | — | — | Mar 12, 2025 |
| BUCHI J. KEVINDirector | Exercise | 51.8k | $3.86 | $200k | Feb 27, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 47.5k | $10.98 | $527k | Dec 24, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 42.0k | $9.60 | $403k | Dec 3, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 41.4k | $9.73 | $417k | Nov 20, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 7.14M | — | $21.14M | Sep 26, 2024 |
Members whose judged calls on BNTC have played out most reliably.
No settled calls on BNTC yet. 1 call is open, the first due Aug 27, 2027.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
7 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 6 | 0 | 0 | 0 | Buy1.75 |
| 1 mo ago | 1 | 6 | 0 | 0 | 0 | Buy1.86 |
| 2 mo ago | 1 | 6 | 0 | 0 | 0 | Buy1.86 |
| 3 mo ago | 1 | 6 | 0 | 0 | 0 | Buy1.86 |